Dose curve [PK / PD]

posted by Sundar.M – India, 2019-02-15 12:37  – Posting: # 19925
Views: 523

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN

Complete thread:

Activity
 Admin contact
20,250 posts in 4,262 threads, 1,397 registered users;
online 19 (0 registered, 19 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 17:47 UTC

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5